As of 2024-12-13, the EV/EBITDA ratio of CorMedix Inc (CRMD) is -11.94. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CRMD's latest enterprise value is 496.88 mil USD. CRMD's TTM EBITDA according to its financial statements is -41.60 mil USD. Dividing these 2 quantities gives us the above CRMD EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2024-12-11 | -13.05 |
| 2024-12-10 | -12.54 |
| 2024-12-09 | -12.79 |
| 2024-12-06 | -13.01 |
| 2024-12-05 | -13.30 |
| 2024-12-04 | -13.27 |
| 2024-12-03 | -13.52 |
| 2024-12-02 | -13.59 |
| 2024-11-29 | -13.53 |
| 2024-11-27 | -13.71 |
| 2024-11-26 | -13.42 |
| 2024-11-25 | -13.67 |
| 2024-11-22 | -13.68 |
| 2024-11-21 | -14.22 |
| 2024-11-20 | -14.82 |
| 2024-11-19 | -15.30 |
| 2024-11-18 | -15.07 |
| 2024-11-15 | -14.22 |
| 2024-11-14 | -15.20 |
| 2024-11-13 | -15.71 |
| 2024-11-12 | -16.17 |
| 2024-11-11 | -16.71 |
| 2024-11-08 | -16.07 |
| 2024-11-07 | -14.66 |
| 2024-11-06 | -14.21 |
| 2024-11-05 | -13.96 |
| 2024-11-04 | -13.14 |
| 2024-11-01 | -13.72 |
| 2024-10-31 | -13.82 |
| 2024-10-30 | -13.81 |
| 2024-10-29 | -18.07 |
| 2024-10-28 | -18.97 |
| 2024-10-25 | -18.17 |
| 2024-10-24 | -17.34 |
| 2024-10-23 | -17.17 |
| 2024-10-22 | -16.71 |
| 2024-10-21 | -15.49 |
| 2024-10-18 | -15.21 |
| 2024-10-17 | -14.45 |
| 2024-10-16 | -14.39 |
| 2024-10-15 | -13.87 |
| 2024-10-14 | -13.83 |
| 2024-10-11 | -13.91 |
| 2024-10-10 | -13.34 |
| 2024-10-09 | -13.64 |
| 2024-10-08 | -13.26 |
| 2024-10-07 | -12.53 |
| 2024-10-04 | -12.13 |
| 2024-10-03 | -11.24 |
| 2024-10-02 | -11.21 |